Residual flow signals predict complete recanalization in stroke patients treated with TPA

被引:53
作者
Labiche, LA [1 ]
Malkoff, M [1 ]
Alexandrov, AV [1 ]
机构
[1] Univ Texas, Sch Med, Stroke Program, Houston, TX USA
关键词
stroke; recanalization; thrombolysis; transcranial Doppler;
D O I
10.1177/1051228402239714
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background. Residual blood flow around thrombus prior to treatment predicts success of coronary thrombolysis. The authors aimed to correlate the presence of residual flow signals in the middle cerebral artery (MCA) with completeness of recanalization after intravenous tissue plasminogen activator (TPA). Methods. The authors studied consecutive patients treated with intravenous TPA therapy who had a proximal MCA occlusion on pretreatment transcranial Doppler (TCD). Patients were continuously monitored for 2 hours after TPA bolus. Absent residual flow signals correspond to the thrombolysis in brain ischemia (TIBI) 0 grade, and the presence of residual flow signals was determined as TIBI 1-3 flow grades. Complete recanalization was defined as flow improvement to TIBI grades 4-5. Results. Seventy-five patients with a proximal MCA occlusion had median pre-bolus NIHSS 16 (85% with greater than or equal to 10 points). TPA bolus was given at 141 +/- 56 minutes (median 120 minutes). Complete recanalization was observed in 25 (33%), partial in 23 (31%), and no early recanalization was seen in 27 (36%) patients within 2 hours after TPA bolus. Only 19% with absent residual flow signals (TIBI grade 0, n = 26) on pretreatment TCD had complete early recanalization. If pretreatment TCD showed the presence of any residual flow (TIBI 1-3, n = 49), 41% had complete recanalization within 2 hours of TPA bolus (P =.03). Conclusions. Patients with detectable residual flow signals before IV TPA bolus are twice as likely to have early complete recanalization. Those with no detectable residual flow signals have less than 20% chance for complete early recanalization with intravenous TPA and may be candidates for intra-arterial therapies.
引用
收藏
页码:28 / 33
页数:6
相关论文
共 22 条
  • [1] Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke - A statement for healthcare professionals from a special writing group of the stroke council, American Heart Association
    Adams, HP
    Brott, TG
    Furlan, AJ
    Gomez, CR
    Grotta, J
    Helgason, CM
    Kwiatkowski, T
    Lyden, PD
    Marler, JR
    Torner, J
    Feinberg, W
    Mayberg, M
    Thies, W
    [J]. CIRCULATION, 1996, 94 (05) : 1167 - 1174
  • [2] Deterioration following spontaneous improvement - Sonographic findings in patients with acutely resolving symptoms of cerebral ischemia
    Alexandrov, AV
    Felberg, RA
    Demchuk, AM
    Christou, I
    Burgin, WS
    Malkoff, M
    Wojner, AW
    Grotta, JC
    [J]. STROKE, 2000, 31 (04) : 915 - 919
  • [3] Intracranial clot dissolution is associated with embolic signals on transcranial Doppler
    Alexandrov, AV
    Demchuk, AM
    Felberg, RA
    Grotta, JC
    Krieger, DW
    [J]. JOURNAL OF NEUROIMAGING, 2000, 10 (01) : 27 - 32
  • [4] Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion
    Arnold, M
    Schroth, G
    Nedeltchev, K
    Loher, T
    Remonda, L
    Stepper, F
    Sturzenegger, M
    Mattle, HP
    [J]. STROKE, 2002, 33 (07) : 1828 - 1833
  • [5] TIMI grade 3 flow and reocclusion after intravenous thrombolytic therapy: A pooled analysis
    Barbagelata, NA
    Granger, CB
    Oqueli, E
    Suarez, LD
    Borruel, M
    Topol, EJ
    Califf, RM
    [J]. AMERICAN HEART JOURNAL, 1997, 133 (03) : 273 - 282
  • [6] Transcranial Doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke
    Burgin, WS
    Malkoff, M
    Felberg, RA
    Demchuk, AM
    Christou, I
    Grotta, JC
    Alexandrov, AV
    [J]. STROKE, 2000, 31 (05) : 1128 - 1132
  • [7] THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) TRIAL, PHASE-I - A COMPARISON BETWEEN INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND INTRAVENOUS STREPTOKINASE - CLINICAL FINDINGS THROUGH HOSPITAL DISCHARGE
    CHESEBRO, JH
    KNATTERUD, G
    ROBERTS, R
    BORER, J
    COHEN, LS
    DALEN, J
    DODGE, HT
    FRANCIS, CK
    HILLIS, D
    LUDBROOK, P
    MARKIS, JE
    MUELLER, H
    PASSAMANI, ER
    POWERS, ER
    RAO, AK
    ROBERTSON, T
    ROSS, A
    RYAN, TJ
    SOBEL, BE
    WILLERSON, J
    WILLIAMS, DO
    ZARET, BL
    BRAUNWALD, E
    [J]. CIRCULATION, 1987, 76 (01) : 142 - 154
  • [8] Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke
    Christou, I
    Alexandrov, AV
    Burgin, WS
    Wojner, AW
    Felberg, RA
    Malkoff, M
    Grotta, JC
    [J]. STROKE, 2000, 31 (08) : 1812 - 1816
  • [9] PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke
    del Zoppo, GJ
    Higashida, RT
    Furlan, AJ
    Pessin, MS
    Rowley, HA
    Gent, M
    [J]. STROKE, 1998, 29 (01) : 4 - 11
  • [10] Thrombolysis in Brain Ischemia (TIBI) transcranial Doppler flow grades predict clinical severity, early recovery, and mortality in patients treated with intravenous tissue plasminogen activator
    Demchuk, AM
    Burgin, WS
    Christou, I
    Felberg, RA
    Barber, PA
    Hill, MD
    Alexandrov, AV
    [J]. STROKE, 2001, 32 (01) : 89 - 93